â??Mapping of Breast Cancer â??Transitionsâ?? to identify the Underlying Biology of Tumour Progression using Next Generation Sequencing (NGS) Technologiesâ??

SCIENCE ENGINEERING RESEARCH BOARD0 个研究点目标入组 9 人开始时间: 待定最近更新: 2022年11月21日

试验速览

暂无简介。

•Patients just diagnosed with recurrent/metastatic breast cancer after a previous diagnosis and treatment of non-metastatic breast cancer OR de nevo metastatic breast cancer
•Patients whose primary tumors are stored in the Tumor Tissue Repository of Tata Memorial Hospital in liquid nitrogen
•Patients willing to provide written informed consent to participate in the study including biopsies from recurrent/metastatic sites and longitudinal follow-up in their metastatic course
•Patients in whom biopsy from recurrent/metastatic sites can be performed with reasonable safety
•Patients whose tumors are triple negative by IHC (ER-/PR-/HER2-)
•Patients willing to receive the usual standard treatment for metastatic breast cancer

发起方

SCIENCE ENGINEERING RESEARCH BOARD